A new report from Deloitte Access Economics highlights the need to address the critical supply and distribution of optometrists throughout Aotearoa to ensure the profession keeps pace with growing demand over the next 20 years. Commissioned by Specsavers, the report analyses optometry needs and work
The American Optometric Association (AOA) has launched Blink Land, a single-player mobile game that teaches players about eye health and its relation to screen time.
EssilorLuxottica is entering the hearing solutions market with proprietary technology which combines prescription glasses and hearing solutions in one product.
With less than a month to go, the Royal Australian and New Zealand College of Ophthalmologists (RANZCO) will welcome delegates to its 54th clinical congress in Perth from 20-23 October. Hosted at the
The phase 2b/3 study of Tarsus Pharmaceuticals’ lotilaner 0.25% ophthalmic solution has shown it to be safe and effective in treating Demodex blepharitis, reported researchers. The US-based Virginia
Researchers at Moorfields Eye Hospital said they identified markers from OCT retinal scans which identified Parkinson’s disease in patients, on average, seven years before they were diagnosed. The
Apellis Pharmaceuticals’ Syfovre, the first FDA-approved drug for geographic atrophy, has been associated with six cases of occlusive retinal vasculitis, warned The American Society of Retinal
Using a new imaging technique, University of Melbourne researchers have discovered the immune cells protecting the cornea are T cells, not dendritic (or Langerhans) cells, as was previously
Belite Bio announced it has completed enrolment for its pivotal global phase 3 DRAGON trial of oral treatment Tinlarebant for patients with Stargardt disease. Tinlarebant is a novel oral therapy
New Zealand researchers are launching a long-Covid registry to get an accurate picture of the country’s post-pandemic burden.
The passing of the Therapeutic Products Bill marks the most significant change to the regulation of medicines, medical devices and natural health products in New Zealand in nearly 40 years, said health minister Dr Ayesha Verrall.
